Karen Bernstein
Fortune : 54 600 $ au 31/05/2026
Fortune : 54 600 $ au 31/05/2026
Karen Bernstein is the founder of BioCentury Publications, Inc. Current positions include Director at Critical Path Institute, Member-Overseers Board at The Scripps Research Institute since 2018, and Trustee at Keck Graduate Institute of Applied Life Sciences since 2009.
Former roles include Independent Director at Achaogen, Inc. from 2017 to 2019, Director at Vitae Pharmaceuticals LLC from 2015 to 2016, Independent Director at Codiak BioSciences, Inc., and Independent Director at Ovid Therapeutics, Inc. Education includes a doctorate from Stanford University and an undergraduate degree from Brandeis University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 20 000 ( 0,01% ) | 54 600 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
BioCentury Publications, Inc.
BioCentury Publications, Inc. Publishing: Books/MagazinesConsumer Services Publishes a bioindustry news. | Fondateur | - |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/09/2009 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/10/2018 |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Directeur/Membre du Conseil | 23/07/2019 |
| VITAE PHARMACEUTICALS INC | Directeur/Membre du Conseil | 25/10/2016 |
| CODIAK BIOSCIENCES | Directeur/Membre du Conseil | - |
| OVID THERAPEUTICS INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Commercial Services |
BioCentury Publications, Inc.
BioCentury Publications, Inc. Publishing: Books/MagazinesConsumer Services Publishes a bioindustry news. | Consumer Services |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national